Venture Capital

Qiming Venture Partners

Qiming Venture Partners is a leading China-based venture capital firm founded in 2006 by Duane Kuang and Gary Rieschel, headquartered in Shanghai with additional offices in Beijing, Suzhou, Hong Kong, Singapore, and a U.S. affiliate (Qiming Venture Partners USA) in Seattle, Washington. The firm invests at the early and growth stages, with roughly 70% of its investments concentrated in Series A and Series B rounds, across two core practice areas: Technology (mobile internet, consumer, AI, robotics, semiconductors, enterprise software, autonomous driving) and Healthcare (biotech, pharmaceuticals, medical devices, diagnostics, and digital health). Qiming manages 11 U.S. Dollar funds and 7 RMB funds with approximately $9.5 billion in capital raised, and has backed more than 580 companies, of which over 210 have exited via IPO on the NYSE, NASDAQ, HKEX, Shanghai, or Shenzhen exchanges, or through M&A. It is an early backer of some of China's most influential technology companies, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Hesai Technology, UBTech, WeRide, Insta360, and Zhipu AI (Z.ai), alongside a deep healthcare portfolio spanning Zai Lab, Gan & Lee Pharmaceuticals, CanSino Biologics, Tigermed, and Insilico Medicine.

374 portfolio companies 3 publish APIs here 13 properties
Venture CapitalSeedSeries ASeries BGrowth EquityTechnologyHealthcareArtificial IntelligenceSemiconductorsRoboticsBiotechChinaAsia

Qiming Venture Partners has 374 portfolio companies tracked on the APIs.io network, of which 3 (1%) publish APIs indexed here.

Its highest-rated API providers on the network are game, tigergraph, Z.ai (Zhipu AI).

Portfolio on the Network

Portfolio companies that publish APIs indexed on APIs.io, grouped by their API Evangelist rating. Exemplar and Strong are expanded by default.

Developing 1 Usable, with meaningful gaps to close
Thin 2 Limited public surface area

Rest of Portfolio

371 further portfolio companies that don’t yet have a provider page on the network.

1hai1yongcloud2duche52TOYS6161draw7k7kabbiskoabcfintechabogenbioabupdateaceabioaceatherapeuticsacxelaeonmedafujingyouai-primeairqualityaistarfishakulakualamarbioalltechmedalphabiopharmaantengeneanxinyishengaohuaaplumapollomicsincappconomyaptmedapusappsarkbiosciencesarrailgroupasierisatantaresatom-semiconductoraxera-techbaoyugamebayomicsbbi-lifesciencesbeijingyuanxinberrygenomicsbesunyenbevaBilibilibiolinkbioscience-tjbiotreebioyondbirentechbjgoodwillblack-uniqueblockvisionbommingbondentbouffalolabbroncusbtrchinabudcreatecaimitechcanbridgepharmacansinotechcashbuscastboxappcdhotcdthchemcehomecencorpcentreherbscetachaitinchangeducationchatailchina-fifchina-richenchinabscchinacachechubaochuhangchumanappchushoucitic-pharmcixtechclearorthodclinflashclounixclubfactorycmlabscncolandpharmacompleteomicsconnectbiopharmcontentboxconvenientpowercoohuacoolcollegecoremedcorpcrownbiocsr-biotechcubenergycuregeneticscuttcygiaddajiabaodeepwaydesanodezhentechdinovamedtechdkmedtechdmedglobaldocindocsdomobdpdstzceigencommeigentechemergenethealthcarefangtekfanlifimifinernfirstgridforgamefrontagelabfrontisfxiaokegalbotgammastarGan & Lee PharmaceuticalsgaugenegeneditbiogenorbioglightmedgohooguahaoguokanggyennohanqigrouphaoyikuhashquarkhealthgenetechHesai Technologyhonesshortorgameshoumohugemedhuimeihxgrouphyperealhyperstronghyperziceonlineidsmanagerigetgetilovewoofimileimmune-pathinbilininfervisioninflyinfstonesinnosticinscinstechinsight-medInsilico MedicineInsta360inventisbioiqi-incitianguaivderjacobiopharmajcxjjfkbiojhtcmjiayuanjinkongautojoesfuturefoodjsgaiyajurenjustmedicalkaiheikejikaixin001kechowpharmakeysinokingswarekintepkktv5koalareadingkuwolagoulanzatechleapstackletelliangyihuiliangzizhigelieshenglih-investlongbiolongwilllpaminaltztherapeuticsluotianyilupuamcm20genomicsmafengwomarvel-techmatrixportmatwingsmech-mindmedicaldlmedmotionmedscimedxtmcmeetfuturemeituMeituanmiaoshoumicropointbiomicrotechmdmitralignmiwuyymk-semimobikemogujiemoodytigermoreticketsmorewismuchomuttoincnasn-autoneiwainovamabnovastnovoproteinnuriennurotronnvxcloudsocegone-chiponeapmoneasporicellorigenepelliotpetkitphotoncrystalpluslifeppspratilipiprcxiprimelifescienceprismlabprmeasureqiangsenmedicalqingflowqiniuquickpicrdbioreddoorzreetianrensenergyRoborockroxmotorruhnnsanegenebiosanyoumedsceneraySchrödingersemsequoiadbsgeetsh-ecoshanzhenshenogenshineheshiyunjishsonglishukunshulanhealthsieredusingularmedicalsinobiologicalsinocelltechsinomdtsinotausinovision-techsnssurgicalspeschinaStepFunsuhsunnydentalsunyursupermagswapsweetomesynapsortt4gametandemaitasogaretellgenthinktransthoroughtigermedtingsntisenctokentongduntongzhuogametpmedicaltranswarptripod-glptrytrytwtuhutujiatungeetutorabcUBTechUnisoundvanclveervenusmedtechvinnovistelvlightvvongihealthvrmedicalwacaiwebcomicsappwecare-bioWeRidewowjoywoxiaoyawx-visionproxbonlinexellsmartxiaomanxiaomishuxiaoniaokuaiyanxiaoyixiudanxskyxy51yanyinyesmroylhyoilyoaaypxfoodyuanbaobaoxianyuanxinjituanyunjichinayunqiyunyingguZai Labzchb-waterzd-medzeenhealthzegozgbiotechzhaohu365zhaosuliaoZhihuzhixiaolezincfivezjbangerzuoshouyishengzuzuche

Scroll for all 371

Properties

Portfolio

Where the firm publishes its investments

Team

Partners and investing staff

Content

Blog, podcast, newsletter, and research

Firm

The firm itself

Other

Everything else declared in apis.yml

Source (apis.yml)

apis.yml Raw ↑
aid: qiming
name: Qiming Venture Partners
description: >-
  Qiming Venture Partners is a leading China-based venture capital firm founded in 2006 by Duane Kuang
  and Gary Rieschel, headquartered in Shanghai with additional offices in Beijing, Suzhou, Hong Kong,
  Singapore, and a U.S. affiliate (Qiming Venture Partners USA) in Seattle, Washington. The firm invests
  at the early and growth stages, with roughly 70% of its investments concentrated in Series A and Series B
  rounds, across two core practice areas: Technology (mobile internet, consumer, AI, robotics,
  semiconductors, enterprise software, autonomous driving) and Healthcare (biotech, pharmaceuticals,
  medical devices, diagnostics, and digital health). Qiming manages 11 U.S. Dollar funds and 7 RMB funds
  with approximately $9.5 billion in capital raised, and has backed more than 580 companies, of which over
  210 have exited via IPO on the NYSE, NASDAQ, HKEX, Shanghai, or Shenzhen exchanges, or through M&A. It is
  an early backer of some of China's most influential technology companies, including Xiaomi, Meituan,
  Bilibili, Zhihu, Roborock, Hesai Technology, UBTech, WeRide, Insta360, and Zhipu AI (Z.ai), alongside a
  deep healthcare portfolio spanning Zai Lab, Gan & Lee Pharmaceuticals, CanSino Biologics, Tigermed, and
  Insilico Medicine.
image: https://www.qimingvc.com/favicon.ico
x-type: venture-capital
x-category: Venture Capital
created: '2026-07-17'
modified: '2026-07-17'
specificationVersion: '0.20'
tags:
  - Venture Capital
  - Seed
  - Series A
  - Series B
  - Growth Equity
  - Technology
  - Healthcare
  - Artificial Intelligence
  - Semiconductors
  - Robotics
  - Biotech
  - China
  - Asia
apis: []
common:
  - type: Website
    url: https://www.qimingvc.com/en
  - type: Portfolio
    url: https://www.qimingvc.com/en/portfolio
  - type: Portfolio
    url: portfolio/qiming-portfolio.yml
  - type: Team
    url: https://www.qimingvc.com/en/team
  - type: Team
    url: team/qiming-team.yml
  - type: InvestmentThesis
    url: https://www.qimingvc.com/en/about
  - type: News
    url: https://www.qimingvc.com/en/newsroom
  - type: Jobs
    url: https://www.qimingvc.com/en/careers
  - type: Pitch
    url: mailto:BP@qimingvc.com
  - type: Contact
    url: mailto:contactus@qimingvc.com
  - type: Crunchbase
    url: https://www.crunchbase.com/organization/qiming-venture-partners
  - type: LinkedIn
    url: https://www.linkedin.com/company/qiming-venture-partners
  - type: Twitter
    url: https://twitter.com/QimingVC
  - type: Features
    data:
      - "Stage: Early and growth stage; ~70% in Series A / Series B"
      - "Sectors: Technology (mobile internet, consumer, AI, robotics, semiconductors, enterprise software, autonomous driving) and Healthcare (biotech, pharmaceuticals, medical devices, diagnostics, digital health)"
      - "Geography: Greater China, with a U.S. affiliate in Seattle"
      - "Capital raised: ~$9.5B across 11 USD funds and 7 RMB funds"
      - "Portfolio: 580+ companies, 210+ IPO exits"
      - "Founded: 2006"
      - "HQ: Shanghai, China (offices in Beijing, Suzhou, Hong Kong, Singapore, Seattle)"
    sources:
      - https://www.qimingvc.com/en/about
      - https://en.wikipedia.org/wiki/Qiming_Venture_Partners
    updated: '2026-07-17'
maintainers:
  - FN: Kin Lane
    email: info@apievangelist.com
    url: https://apievangelist.com
  - FN: APIs.json
    url: http://apisjson.org
  - FN: Qiming Venture Partners
    url: https://www.qimingvc.com/en